Clinical Trials Directory

Trials / Completed

CompletedNCT03595254

Digital Cognitive Behavior Therapy Program for Suicide Prevention

Thrive-Montana: A Computerized Cognitive Behavior Therapy (cCBT) Program to Reduce Depression, Anxiety, Suicidal Ideation and Behaviors for Rural Montanans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
725 (actual)
Sponsor
Montana State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study evaluates the efficacy of Thrive, a computerized cognitive behavior therapy program, to reduce depression and anxiety symptoms and to reduce suicidal thinking among adults. The first 450 participants will participate in a randomized waitlist controlled trial. The remaining 550 participants will be provided the program immediately upon enrolling

Detailed description

The efficacy of Thrive has been studied among patient and community populations and has shown to effectively reduce depression and anxiety symptoms among adults with moderate to severe depression symptoms at baseline. This study will examine whether Thrive can also reduce suicidal thinking for persons exhibiting at least moderate depression symptoms. The first phase of the study will implement a randomized waitlist controlled trial. The second phase of the study will examine the effects in a open trial. Outcome assessments will occur at baseline, 4- and 8-weeks (12- and 16-weeks for the waitlist group) with a 6-month follow-up assessment for all participants.

Conditions

Interventions

TypeNameDescription
BEHAVIORALThriveComputerized Cognitive Behavior Therapy program

Timeline

Start date
2018-11-16
Primary completion
2020-04-08
Completion
2020-04-08
First posted
2018-07-23
Last updated
2020-09-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03595254. Inclusion in this directory is not an endorsement.